# Subacromial Methylprednisolone Versus Ketorolac for Shoulder Impingement

> **NCT03913702** · PHASE2 · TERMINATED · sponsor: **The University of Texas Medical Branch, Galveston** · enrollment: 1 (actual)

## Conditions studied

- Subacromial Impingement
- Subacromial Impingement Syndrome

## Interventions

- **DRUG:** Ketorolac Tromethamine
- **DRUG:** Methylprednisolone Acetate

## Key facts

- **NCT ID:** NCT03913702
- **Lead sponsor:** The University of Texas Medical Branch, Galveston
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-09-09
- **Primary completion:** 2022-11-02
- **Final completion:** 2022-11-02
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Inadequate patient enrollment
- **Last updated:** 2025-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03913702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03913702, "Subacromial Methylprednisolone Versus Ketorolac for Shoulder Impingement". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03913702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*